-

IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025

Sustainability Expert Will Share Key Insights on Industry-Leading Solutions for Improving Environmental Impact

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable innovations, controlled-release formulations, and nitrosamine risk mitigation solutions at booth 205 from May 13-14, Gaylord National Resort and Convention Center, National Harbor, Maryland, USA.

“At IFF Pharma Solutions, we believe sustainability is not just a responsibility but an opportunity to innovate and inspire,” said Dr. Anne Adden, global strategic marketing director for sustainability and dietary supplements. “We are committed to creating solutions that not only meet the needs of today but also pave the way for a healthier, more sustainable future. Our team of problem-solvers and experts is redefining what it means to lead in sustainable healthcare.”

Building on over 75 years of industry expertise, IFF Pharma Solutions is ready to present its diverse portfolio of offerings. This includes METHOCEL™ — Pioneering Then, Innovating Now; ETHOCEL™ — Proven Time After Time and POLYOX™ — Versatile Across Complex and Unique Applications. Our experts will also showcase the newly introduced Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) and Avicel® PH LN, both developed to reduce nitrosamine risks in pharmaceutical formulations.

Dr. Anne Adden will present “Sustainable by Design: The Future of Excipients” on May 13, from 2:00 to 2:45 p.m. ET, in the Riverview Ballroom, Stage 2. She will discuss how IFF Pharma Solutions incorporates sustainability at every stage of excipient manufacturing, from sourcing materials to packaging.

Visit here to learn more about IFF Pharma Solutions.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contacts

Emily Kaufman
Global Communications Specialist
+1 908.670.5691
emily.kaufman@iff.com

International Flavors & Fragrances

NYSE:IFF

Release Versions

Contacts

Emily Kaufman
Global Communications Specialist
+1 908.670.5691
emily.kaufman@iff.com

More News From International Flavors & Fragrances

IFF Introduces Smart Dosing Robot to Transform Fragrance Production

CHIN BEE, Singapore--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences, has implemented the Colibri robot in its Chin Bee production facility. This advanced industrial dosing system can produce fragrance sample batches on demand in minutes, reimagining and expediting the fragrance development journey for local, regional and global customers in Greater Asia. The new robotic system, installed at the company's cross-category Scent a...

IFF Benicarló Pioneers On-Site Green Hydrogen Production Facility for Sustainable Fragrance Ingredient Manufacturing

BENICARLÓ, Spain--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences, announced the installation of a nature-based hydrogen production facility at its Scent R&D and fragrance ingredients manufacturing plant in Benicarló, Spain. The site has partnered with Iberdrola, one of the world’s largest producers of renewable energy, to become the first in the fragrance industry to rely on renewable electricity for hydrogenation reactions used in...

IFF Reports Third Quarter 2025 Results

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.7 B   $56 M   $0.16   $519 M   19.3%   $1.05 First Nine Months 2025 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBI...
Back to Newsroom